Featured Research

from universities, journals, and other organizations

HIV vaccine preventing healthy cells' infection

Date:
November 26, 2013
Source:
youris.com
Summary:
AIDS research has attempted many strategies to tackle the HIV virus infection. Now,a new type of vaccineis based on one of the envelope proteins of the HIV virus, called the gp41 protein. What makes it interesting is that it is directly responsible for the fusion of the HIV virus into human cells. By integrating the gp41 protein into the vaccine, researchers try totrigger the production of antibodies that would block the entrance of HIV into human cells.

T cell. “The idea basically is that a vaccine should induce antibodies T cells immune response, that would neutralise HIV in all of its forms,” explains Ulrich Fruth, vaccine development and evaluation team leader at the World Health Organisation, in Geneva, Switzerland.
Credit: youris.com

AIDS research has attempted many strategies to tackle the HIV virus infection. Now, a new type of vaccine developed within an EU-funded project, called EuroNeut-41, is based on one of the envelope proteins of the HIV virus, called the gp41 protein. What makes it interesting it that it is directly responsible for the fusion of the HIV virus into human cells. By integrating the gp41 protein into the vaccine, researchers try to trigger the production of antibodies that would block the entrance of HIV into human cells.

Related Articles


"We have used an innovative approach, combining protein engineering, specific vaccine formulation and a combination of routes of administration, [nasal] and intramuscular," explains Nicolas Mouz, chief scientific officer at PX'Therapeutics, one of the project partners. The company is also providing services, in protein engineering research and manufacturing and it is located in Grenoble, France.

There have been many trials since the discovery of the virus, in the early 1980s, to create both a cure for infected people and a preventative therapy to stop the contagion. "This gp41 protein from the virus envelope is not an absolute novelty in the long history of anti HIV vaccine development," says Alexandru Rafila, Chairman of the Romanian Society for Microbiology in Bucharest. "But it is a meaningful approach in protein design that could be given as a vaccine so that it triggers an immune response."

The trouble is that the virus targets not only the lymphocyte cells, which include T cells -- a key component of the body's immune system helping to fight diseases -- but also other immune system cells. The latter are not exclusively infected through the gp41 protein but also through other mechanisms. "An efficient vaccine should hamper the infection of any other cells," Rafila tells youris.com.

Other experts concur that the diversity of HIV and its enormous capacity to mutate are some of the main challenges for vaccine development. "The idea basically is that a vaccine should induce antibodies T cells immune response, that would neutralise HIV in all of its forms," explains Ulrich Fruth, vaccine development and evaluation team leader at the World Health Organisation, in Geneva, Switzerland.

Even though Fruth considers the project strategy an excellent approach, chances of success of this vaccine are difficult to foresee. "We just don't know," he says, "The only thing we know is that we have more experience on human trials. The animal models used so far were not very predictive. We need human clinical trial in order to decide which vaccine to take forward," he concludes. The vaccine is in its first stage of clinical safety's studies, which proved to have a relatively weak effect. It is too early to provide an explanation to such results.

In addition, Fruth points to a minor limitation of this vaccine, namely that it focuses on the induction of antibodies. He concludes: "we think that for a successful protection we may need [to target] both: antibodies and T cells. The role that I would see for such a vaccine would probably be in combination with the components that induce T cell immune response. So, [what may proved useful is to test] a combination vaccine [and] not a standalone one."


Story Source:

The above story is based on materials provided by youris.com. Note: Materials may be edited for content and length.


Cite This Page:

youris.com. "HIV vaccine preventing healthy cells' infection." ScienceDaily. ScienceDaily, 26 November 2013. <www.sciencedaily.com/releases/2013/11/131126123835.htm>.
youris.com. (2013, November 26). HIV vaccine preventing healthy cells' infection. ScienceDaily. Retrieved November 1, 2014 from www.sciencedaily.com/releases/2013/11/131126123835.htm
youris.com. "HIV vaccine preventing healthy cells' infection." ScienceDaily. www.sciencedaily.com/releases/2013/11/131126123835.htm (accessed November 1, 2014).

Share This



More Health & Medicine News

Saturday, November 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Melafind: Spotting Melanoma Without a Biopsy

Melafind: Spotting Melanoma Without a Biopsy

Ivanhoe (Oct. 31, 2014) The MelaFind device is a pain-free way to check suspicious moles for melanoma, without the need for a biopsy. Video provided by Ivanhoe
Powered by NewsLook.com
Battling Multiple Myeloma

Battling Multiple Myeloma

Ivanhoe (Oct. 31, 2014) The answer isn’t always found in new drugs – repurposing an ‘old’ drug that could mean better multiple myeloma treatment, and hope. Video provided by Ivanhoe
Powered by NewsLook.com
Chronic Inflammation and Prostate Cancer

Chronic Inflammation and Prostate Cancer

Ivanhoe (Oct. 31, 2014) New information that is linking chronic inflammation in the prostate and prostate cancer, which may help doctors and patients prevent cancer in the future. Video provided by Ivanhoe
Powered by NewsLook.com
Sickle Cell: Stopping Kids’ Silent Strokes

Sickle Cell: Stopping Kids’ Silent Strokes

Ivanhoe (Oct. 31, 2014) Blood transfusions are proving crucial to young sickle cell patients by helping prevent strokes, even when there is no outward sign of brain injury. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins